Inventor

BODOR NICOLAE S

47 patents

⚠️ This page may combine multiple inventors who share the name “BODOR NICOLAE S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BODOR NICOLAE S

INTERX RESEARCH CORP

Labile, non-heterocyclic quaternary ammonium salt/esters as transient derivatives

Treating psoriasis with transient pro-drug forms of xanthine derivatives

Novel, transient pro-drug forms of L-DOPA to treat Parkinson&#39;s disease

Novel, transient pro-drug forms of l-dopa

Novel, transient pro-drug forms of l-dopa useful in the treatment of parkinson&#39;s disease

Intermediates useful in the synthesis of optically active m-acyloxy-α-[(methylamino)methyl]benzyl alcohols

Labile quaternary ammonium salts as prodrugs

Soft quaternary surface active agents and method of using same

Method of inhibiting bacterial growth with certain selected 3-chloro-2-oxazolidinones

3-Chloro-2-oxazolidinones

N-Nicotinoyl-3,4-dinicotinoyloxy-L-phenylalanine and derivatives pharmaceutical compositions and methods containing same

Selected quaternary ammonium salts of pilocarpine useful in reducing intraocular pressure in warm-blooded animals

1-hydrocarbonoyloxymethyl-3-carbamoyl or 3-carboethoxy-pyridinium salts

Novel pro-drug derivatives of pyridinium aldoxime type cholinesterase reactivators and method of using same

Pro-drugs for the improved delivery of certain selected anti-inflammatory steroids

N-chloro-amino acid derivatives exhibiting antibacterial activity

Pro-drug forms of digoxin and method of preparing and using same

Soft quaternary surface active agents exhibiting antibacterial activity

N-chloro-amino acid derivatives activity

Certain transient pro-drug forms of phenylbutazone

Stable pro-drug forms of theophylline

Useful pro-drug forms of theophylline

Novel optically active m-acyloxy-α-[(methylamino)methyl]benzyl alcohols and the pharmaceutically acceptable acid addition salts thereof

Novel synthesis for preparing the hydrochloride salt of selected catecholamine derivatives

Novel synthesis of optically active m-acyloxy-α-[(methylamino)methyl]benzyl alcohols, the pharmaceutically acceptable acid addition salts thereof and intermediate useful in the preparation thereof

Nonbitter tasting potassium product for oral administration to warm-blooded animals and method for preparing same

1,2-Diphenyl-3,5-ditrifluoroacetyloxy-4-butyl-5-hydroxy-3-pyrazoline

Transient pro-drug forms of phenylbutazone

Antibacterial novel soft n-chloroamino alcohol derivatives

Novel soft N-chloroamino alcohol derivatives exhibiting antibacterial activity

3-Chloro-1,3-oxazines or oxazolidines as antibacterial agents

Novel transient acyl derivatives of phenylbutazone

Certain chloroamino esters of pyridine carboxylates and derivatives thereof

Brominating and oxidizing agent and method of using same

3-Chloro-tetrahydro-1,3-oxazines or oxazolidines spiro substituted

Useful pro-drug forms of theophylline

Intermediates useful in the preparation of optically and therapeutically active-m-acyloxy-(methyl-amino) methyl benzyl alcohols

Novel intermediates useful in the synthesis of optically active m-acyloxy-α-[(methylamino)methyl]benzyl alcohols

Antibacterially active N-chloroamino ester derivatives of alkyl carboxylates

Labile quaternary ammonium salts useful in binding bile acids in warm-blooded animals

Novel soft N-chloroamino alcohol derivatives exhibiting antibacterial activity

Labile quaternary ammonium salts useful in binding bile acids in warm-blooded animals

Method of arresting bacterial growth with certain selected dichloro-2,2,5,5-tetrasubstituted-3-6-piperazinediones

Method for inhibiting bacterial growth with certain selected 3-chloro-tetrahydro-1,3-oxazines or oxazolidines

Method for synthesizing certain selected pro-drug forms of theophylline

MERCK & CO INC

Soft quaternary surface active agents

INTERNX RESEARCH CORP

Labile quaternary ammonium salts useful in binding bile acids in warm-blooded animals

Novel, transient pro-drug forms of L-DOPA to treat Parkinson's disease

Novel, transient pro-drug forms of l-dopa useful in the treatment of parkinson's disease